Complete androgen insensitivity syndrome (CAIS) is a disorder of sex development with an incidence of 1 in 20,000-99,000 in genetic males. It is caused by loss of function mutations of the androgen receptor gene in individuals with an XY genotype. The gene encoding the androgen receptor is located on Xq containing 8 exons. A number of mutations have been identified in these 8 exons. 1,2 Individuals with CAIS are phenotypically female with normal female external genitalia. The most common symptom is primary amenorrhea, although the diagnosis may be made earlier when there is a discrepancy between antenatal and postnatal phenotype or when an inguinal hernia in a young girl is found to contain a testis. Traditional management of CAIS includes gonadectomy with subsequent hormonal replacement. Gonadectomy is indicated owing to the increased incidence of gonadal tumors in CAIS, which range from 0.8% to 16%. Current practice is to perform gonadectomy in late adolescence after completion of spontaneous pubertal development 1 .
Although the risk of gonadal tumor development is considered to be low, a variety of tumors have been described in association with CAIS. The case we present, a unilateral paratesticular leiomyoma developing concurrently with bilateral Sertoli cell adenomas, is very rarely reported in the literature.
female, presented to our clinic for amenorrhea. Her history involved surgery for left inguinal hernia at the age of 2. The patient's niece of the same age was diagnosed with CAIS at our department and had undergone gonadectomy six months ago. The patient had four more nieces with the same diagnosis. The phenotypically female patient's physical examination revealed: height 164.7 cm (-1.53 SDS), weight 54.5 kg (-2 SDS), breast development Tanner stage 5, and pubic hair development Tanner stage 2 with scarce axillary hair development. A gonad was palpable in the left inguinal region. Chromosome analysis was 46, XY, and the sex-determining region Y (SRY) was positive. Her laboratory analysis revealed LH 18.6 mIU/ml (1.7-11), FSH 0.7 mIU/ml (1.4-11.7), total testosterone 702 ng/dl (8-80), E2 31. Mullerian (tuba uterina) and Wolfian cystic structures were also observed. Figure 5 shows the histopathological images from the biopsy material.
Discussion
Complete androgen insensitivity syndrome (CAIS) is a sexual development disorder due to mutations that cause function loss in androgen receptors in 46, XY individuals. It is characterized by a male karyotype and abnormal female phenotype with the absence of Mullerian duct derivatives and the presence of female breast development, although no Complete Androgen Insensitivity Syndrome axillary or pubic hair is observed 2 . Hormonal measurements classically reveal a plasma testosterone concentration that is within the normal range for males. However, some patients have elevated plasma testosterone as in our patient, due to increased response to stimulation by luteinizing hormone (LH). On the other hand, plasma follicle-stimulating hormone (FSH) concentrations might be within the normal range, and normal or elevated plasma LH concentrations may result from hypothalamo-pituitary refractoriness to the negative feedback of testosterone 2 .
The complete androgen insensitivity syndrome may be familial or sporadic 3 . Our patient's niece had been diagnosed with CAIS at our clinic and gonadectomy had been performed six months before. The patient also had four other nieces with the same diagnosis. The diagnosis is usually suspected at puberty because of amenorrhea, but can sometimes be made at an early age upon the discovery of an inguinal hernia or after the condition is revealed in an affected sibling. It may also occasionally be discovered after marriage, even at an advanced age, as reported in an 84-year-old patient when an abdominal tumor became apparent 3 . About 50% of the patients have an inguinal hernia. Conversely, 1-2% of apparently female infants with inguinal hernia are diagnosed as having a 46, XY karyotype and CAIS 4 . Our patient was assessed for inguinal hernia when she was 2 years old but unfortunately had not been diagnosed at that time.
The standard practice is to recommend gonadectomy to all patients with CAIS after the completion of puberty, usually at the age of 16 years 1 . The estimated risk of malignant development in the testes is 5%-10% until 25 years of age and increases thereafter to reach 33% at the age of 50 2 . In a case series of 43 patients with androgen insensitivity syndrome by Rutgers and Scully, hamartomas made up 63%, sertoli cell adenomas 23% and malignant tumors including two seminomas, one intratubular germ cell neoplasm with early stromal invasion and a malignant sex cord tumor 9% 5 . Sertoli-Leydig cell tumors are uncommon neoplasms, accounting for only 1% of all sex-cord stromal tumors 2 . It is possible that gonadotropins induce gonocyte proliferation in the development of testicular cancer, and there is a positive correlation between elevated gonadotropins and the number of premeiotic germ cells. Some authors have tried to explain the relationship between this syndrome and neoplasia development, and have proposed a hypothesis of increased susceptibility due to the absence of germ cell differentiation, with gonocytes developing in a neoplastic manner 6 .
Leiomyomas are generally very unusual tumors in the urogenital tract, and especially in the testis or epididymis. Leiomyomas are also extremely rare in removed gonads from androgen insensitivity syndrome patients, with only three similar cases reported in the literature [7] [8] [9] . Their location may be intratesticular or paratesticular, and the origin is believed to be the smooth muscle cells of the interstitial stroma, the muscular layer of the vessels of the tunica albuginea, the seminiferous tubules, as well as paratesticular structures (spermatic cord, epididymis, vestigial remnants, and tunica vaginalis), although tubular genital structures are aplastic in CAIS patients due to the lack of androgen response 7 . The case we presented is very rarely reported in the literature with a right paratesticular leiomyoma developing concurrently with bilateral Sertoli cell adenomas.
